English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Shanghai Acebright Buys 10% of Israeli NasVax

Jun. 30, 2013

Acebright Holdings Ltd. signed a MOU with NasVax Ltd. under which it will invest $1 million in NasVax for a 10% stake in the company. NasVax is developing two novel drugs, an immunotherapy drug and a treatment for Alzheimer's.